StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.71−0.25 (-2.79%)

Close on Nov 19, 2026Market cap $2.95BP/E –Yield –

Telix Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$42.99M, down 334.0% from the year before.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$42.99M-334.0%
FY2024Dec 31, 2024$18.37M+130.6%
FY2023Dec 31, 2023$7.97M–

More Telix Pharmaceuticals figures

See a number that looks wrong?